Using Big Data to Discover Potential Cancer Biomarkers
News Aug 11, 2016
"These biomarkers are highly accurate and robust, up to 97 percent, and could be developed into an early screening test for all types of cancers. We find that early detection and prevention is key for the survival and quality of life of cancer patients. This could benefit patients in Hawai'i and around the world," said Lana Garmire, PhD, an assistant professor in the Cancer Epidemiology Program at the UH Cancer Center.
Garmire, a translational bioinformatics expert who is successful at obtaining competitive NIH grants, used a powerful data mining approach to search through thousands of cancer organ tumor samples and large data sets to find the panel of lincRNAs.
LncRNAs as Cancer Biomarkers
Garmire's findings published in EBiomedicine highlight lincRnas as the most recently discovered new class of RNA molecules. The advancement of technologies has enabled the identification of tens of thousands of new lincRNAs. Researchers found the molecules to be excellent candidates for cancer biomarkers. Compared to protein coding genes, lincRNAs expression patterns are more specific to particular tissues and developmental stages, and thus could be better biomarkers for cancers.
"We have worked on this study for the last two years, and are at the verge of discovering something very useful. Thanks to the High Performance Computing (HPC) facility at UH Manoa, we have been using a Big Data analytics approach to start our hypothesis with massive data evidence before validating it in the lab," said Garmire.
The panel of biomarkers has been approved as a provisional patent, and Garmire is working on securing licensing.
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
"Genetic Jenga" Helps Understand How Our Genes Control Our CellsNews
To fully understand how our cells work, we can't focus on just one gene, but must instead look at combinations of genes. Researchers have published a study which knocked out multiple genes, like removing bricks from a Jenga tower, to better understand how they work together.READ MORE